| Dr Lucia Astrid Garino, MD | |
|
11850 Blackfoot St Nw, Suite 100, Coon Rapids, MN 55433-2598 | |
| (763) 721-2100 | |
| (763) 721-2190 |
| Full Name | Dr Lucia Astrid Garino |
|---|---|
| Gender | Female |
| Speciality | Medical Oncology |
| Experience | 33 Years |
| Location | 11850 Blackfoot St Nw, Coon Rapids, Minnesota |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1104836154 | NPI | - | NPPES |
| 1022445 | Other | MN | PREFERRED ONE |
| 3611173 | Other | MN | MEDICA |
| 410729979 | Other | MN | COMMERCIAL |
| 3611173 | Other | MN | SELECT CARE |
| HP29973 | Other | MN | HEALTH PARTNERS |
| 452223100 | Medicaid | MN | |
| 124399 | Other | MN | UCARE |
| 13D68GA | Other | MN | BLUE SHIELD |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RH0003X | Internal Medicine - Hematology & Oncology | 41470 (Minnesota) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Mercy Hospital | Coon rapids, MN | Hospital |
| Abbott Northwestern Hospital | Minneapolis, MN | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Minnesota Oncology Hematology, Pa | 6709799752 | 104 |
News Archive
A protein typically associated with neurodegenerative diseases like Alzheimer's might help scientists explore how gliomas, a type of cancerous brain tumor, become so aggressive.
Today, Sepsis Alliance and the National Association of Emergency Medical Technicians released the results of their Sepsis and EMS survey.
Seattle Children's Research Institute and biotechnology company Kineta, Inc. today launched the Alliance for Children's Therapeutics (ACT), a first-of-its-kind pediatric research and funding collaboration designed to speed development of new medications for children and teens with lupus nephritis and other autoimmune diseases like multiple sclerosis, Type 1 diabetes and rheumatoid arthritis.
Zelos Therapeutics, Inc. has initiated dosing in a seven day clinical study of a nasal spray formulation of ZT-034 (teriparatide) that is being developed in collaboration with development partner Aegis Therapeutics, LLC. Nasal spray ZT-034 is being developed as an alternative to Eli Lilly and Company's Forteo (teriparatide [rDNA origin]) which generated approximately $800M in annual sales in 2009 for the treatment of osteoporosis and is administered by daily injection.
The recent explosion in the number of retractions in scientific journals is just the tip of the iceberg and a symptom of a greater dysfunction that has been evolving the world of biomedical research say the editors-in-chief of two prominent journals in a presentation before a committee of the National Academy of Sciences (NAS) today.
› Verified 6 days ago
| Entity Name | Minnesota Oncology Hematology, Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1528035995 PECOS PAC ID: 6709799752 Enrollment ID: O20031106000626 |
News Archive
A protein typically associated with neurodegenerative diseases like Alzheimer's might help scientists explore how gliomas, a type of cancerous brain tumor, become so aggressive.
Today, Sepsis Alliance and the National Association of Emergency Medical Technicians released the results of their Sepsis and EMS survey.
Seattle Children's Research Institute and biotechnology company Kineta, Inc. today launched the Alliance for Children's Therapeutics (ACT), a first-of-its-kind pediatric research and funding collaboration designed to speed development of new medications for children and teens with lupus nephritis and other autoimmune diseases like multiple sclerosis, Type 1 diabetes and rheumatoid arthritis.
Zelos Therapeutics, Inc. has initiated dosing in a seven day clinical study of a nasal spray formulation of ZT-034 (teriparatide) that is being developed in collaboration with development partner Aegis Therapeutics, LLC. Nasal spray ZT-034 is being developed as an alternative to Eli Lilly and Company's Forteo (teriparatide [rDNA origin]) which generated approximately $800M in annual sales in 2009 for the treatment of osteoporosis and is administered by daily injection.
The recent explosion in the number of retractions in scientific journals is just the tip of the iceberg and a symptom of a greater dysfunction that has been evolving the world of biomedical research say the editors-in-chief of two prominent journals in a presentation before a committee of the National Academy of Sciences (NAS) today.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Lucia Astrid Garino, MD 2550 University Ave W Ste 110n, Saint Paul, MN 55114-2001 Ph: (651) 602-5309 | Dr Lucia Astrid Garino, MD 11850 Blackfoot St Nw, Suite 100, Coon Rapids, MN 55433-2598 Ph: (763) 721-2100 |
News Archive
A protein typically associated with neurodegenerative diseases like Alzheimer's might help scientists explore how gliomas, a type of cancerous brain tumor, become so aggressive.
Today, Sepsis Alliance and the National Association of Emergency Medical Technicians released the results of their Sepsis and EMS survey.
Seattle Children's Research Institute and biotechnology company Kineta, Inc. today launched the Alliance for Children's Therapeutics (ACT), a first-of-its-kind pediatric research and funding collaboration designed to speed development of new medications for children and teens with lupus nephritis and other autoimmune diseases like multiple sclerosis, Type 1 diabetes and rheumatoid arthritis.
Zelos Therapeutics, Inc. has initiated dosing in a seven day clinical study of a nasal spray formulation of ZT-034 (teriparatide) that is being developed in collaboration with development partner Aegis Therapeutics, LLC. Nasal spray ZT-034 is being developed as an alternative to Eli Lilly and Company's Forteo (teriparatide [rDNA origin]) which generated approximately $800M in annual sales in 2009 for the treatment of osteoporosis and is administered by daily injection.
The recent explosion in the number of retractions in scientific journals is just the tip of the iceberg and a symptom of a greater dysfunction that has been evolving the world of biomedical research say the editors-in-chief of two prominent journals in a presentation before a committee of the National Academy of Sciences (NAS) today.
› Verified 6 days ago
Dr. Jaya Bhattarai, MD Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 4050 Coon Rapids Blvd Nw, Coon Rapids, MN 55433 Phone: 763-236-6000 | |
Zongyu J Chen, MD Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 9145 Springbrook Dr, #200, Coon Rapids, MN 55433 Phone: 612-871-1145 Fax: 612-870-5491 | |
Amber Galarowicz, Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 4050 Coon Rapids Blvd Nw, Coon Rapids, MN 55433 Phone: 763-236-6000 | |
Evan L Domeyer, DO Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 3960 Coon Rapids Blvd Nw, 100, Coon Rapids, MN 55433 Phone: 763-236-9400 Fax: 763-236-9423 | |
Natalia Yazigi, M.D. Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 9055 Springbrook Dr Nw, Coon Rapids, MN 55433 Phone: 763-780-9155 | |
Linda Benjamin Soucie, MD Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 3960 Coon Rapids Blvd Nw, 100, Coon Rapids, MN 55433 Phone: 763-236-9400 Fax: 763-236-9423 | |
Wendoly R Slattery, MD Hematology & Oncology Medicare: Not Enrolled in Medicare Practice Location: 9055 Springbrook Dr Nw, Coon Rapids, MN 55433 Phone: 763-780-9155 |